Nanjing Mainoway Pharmaceutical

Nanjing Mainoway Pharmaceutical is a specialized pharmaceutical company based in China, operating as a key subsidiary of the Ningbo Menovo Pharmaceutical Group. The company focuses on the research, development, and large-scale production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, particularly in the cardiovascular, central nervous system, and gastrointestinal therapeutic areas. Its facilities are designed to meet international GMP standards, supporting both domestic supply and global exports to regulated markets. Nanjing Mainoway plays a critical role in the parent group's integrated industrial chain, bridging the gap between advanced chemical synthesis and commercial drug manufacturing.